Journal of Clinical Psychopharmacology

Papers
(The median citation count of Journal of Clinical Psychopharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Trazodone and Mianserin for Delirium37
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia36
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates31
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition26
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report24
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman20
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease20
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients20
Author Index 202219
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?18
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms15
Possibly Misleading Pharmaceutical Advertising On TV15
Dysphagia to Liquids Only Associated With Olanzapine14
Postinjection Syndrome After Paliperidone?14
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration14
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient13
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment13
Question13
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation13
Thoughts on the Value of Case Series in the Literature12
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings12
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia12
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?12
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting12
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy12
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience12
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia11
Drug-Associated Liver Injury Related to Antipsychotics11
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux11
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior11
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus11
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice10
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use10
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders10
Drug Interaction Between Clozapine and Rifampicin10
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin10
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy10
Escitalopram-Associated Drug Rash10
SALUTE TO OUR REVIEWERS10
Restless Legs Syndrome Associated With Brexpiprazole10
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With Schizophrenia9
Neuroleptic Malignant Syndrome Associated With Lurasidone9
Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers9
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment During Clozapine Treatment9
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio9
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders9
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum9
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine8
Inverse Association Between Persistence With Antidepressant Medication and Onset of Chronic Pain in Patients With Depression8
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine8
Aripiprazole as First-Line Therapy for Late-Life Depression8
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine8
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets8
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder8
Journal of Clinical Psychopharmacology Updates8
Question7
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia7
Factors Associated With Poor Response to Clozapine in Schizophrenia7
Question7
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature7
Use of Clozapine in Pregnancy7
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report7
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine7
Untreated Mental Illness Has Created a National Tragedy7
A Manic Episode With Psychotic Features Associated With Levetiracetam7
Fluvoxamine Augmentation of Clozapine and Dose-dependent Interaction Patterns7
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE1047
The Clinical and Economic Burden of Tardive Dyskinesia in Israel7
Incorporating Real-World Treatment Data Into Clozapine's Product Label6
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient6
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient6
Resolution of Catatonia With Cariprazine—A Case Report6
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer6
Plasma Clozapine in Treatment Refractory Schizophrenia6
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review6
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature6
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials6
Alpha Lipoic Acid for Schizophrenia6
Clozapine- and Lithium-Associated Myoclonus6
Clozapine-Associated Agranulocytosis6
Clozapine Use in Down Syndrome6
Mania-Like Reaction Secondary to Sodium Oxybate6
Mania Associated With Cariprazine6
Limitations in Recent Study of Clozapine Use During Pregnancy6
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist6
Pharmacokinetics of Ketamine Transfer Into Human Milk6
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan6
Author Index 20245
Subject Index 20225
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders5
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder5
Clozapine Associated Periorbital Edema in First Episode Psychosis5
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder5
Hematological and Other Cancers in People Using Clozapine5
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants5
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder5
A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II)5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD5
Valproic Acid–Associated Hyperammonemia5
Esketamine for Unipolar Major Depression With Psychotic Features4
Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine4
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder4
Exploring the Addictive Potential of Tranylcypromine4
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma4
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation4
Article Selected to Receive the Mitchell B. Balter Award for 20224
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression4
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning4
Detecting Anxious Distress, an Important Mood Specifier4
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients4
Response to Letter to the Editors From Prof D. Taylor4
You Shall Not Turn a Blind Eye to Intraocular Pressure4
Neurotoxicity Related to Multidrug Association: A Case Report4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series4
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty4
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period4
Methylphenidate-Associated Syncope4
The Need for Non-profit Psychiatric Drug Discovery and Development4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report4
How Does Drug Company Marketing Affect Physician Prescribing?3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease3
Question3
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine3
Fact Versus Fear3
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data3
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine3
Toxidrome of an Easily Obtainable Nootropic3
Ketamine and Esketamine for Depression in Daily Practice3
Tardive Dyskinesia Suppressed With Ginkgo Biloba3
Journal of Clinical Psychopharmacology Updates3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine3
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States3
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome3
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic3
Sertraline-Associated Burning Mouth Syndrome3
α-PVP Associated Psychosis3
Reply to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”3
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium3
A First Trimester Exposure to Ketamine and Esketamine for Depression3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion3
Venlafaxine-Associated Rhabdomyolysis3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants3
Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia3
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings3
Characterization of Extended-Release Lorazepam3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination3
Journal of Clinical Psychopharmacology Updates3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse3
Modafinil Use in an Adolescent With Major Depressive Disorder3
Severe Alprazolam Withdrawal With Delirium and Psychosis3
Evaluating the Quality of Randomized Controlled Trials3
Risk of Neutropenia Associated With Duloxetine3
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications3
Reply to “Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia”3
Catatonia Associated With Valbenazine Treatment3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder3
Panic Disorder Seeks More Specific Drugs for Treatment3
Assessing Adherence to Clozapine3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine3
Global Insights Into Antipsychotic Research3
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination2
Painful Ejaculation Associated With Atomoxetine and Bupropion2
Antidepressant Poisoning Trends in Pediatric Intensive Care2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine2
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder2
Question2
Question2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”2
Ketamine's Altered States Meta-Analysis2
Advancing the Development of New Medications to Treat Psychiatric Illness2
Direct-to-Consumer Advertising Survey of Psychiatrists in Massachusetts and Michigan2
Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine2
Question2
Gastrointestinal Hemorrhage After Antidepressant Drug Use2
Late-Onset Neutropenia With Clozapine Associated With Lithium Carbonate–Related Hyperthyroidism2
Variability in Response to Antidepressants2
Question2
Semaglutide-Mediated Lithium Toxicity2
Effects of Adjunctive Brexpiprazole in Major Depressive Disorder Analyzed by Baseline Anxiety Level2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia2
Sleep-wake Disorders2
Effect of Coffee and Chocolate Ingestion on Clozapine Dose and on Plasma Clozapine and Norclozapine Concentrations in Clinical Practice2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-192
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia2
Statistical Versus Clinical Significance2
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder2
Adverse Reactions to Clozapine2
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder2
Treatment History Characteristics Associated With Use of Isocarboxazid2
Clinician Reasons for Stopping Clozapine2
Response of Gambling Disorder to Semaglutide2
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes2
Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association2
The Rise and Fall of the Age of Psychopharmacology2
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series2
Exploratory Case Series Assessing the Potential Interaction Between Lithium and Sodium-Glucose Cotransporter-2 Inhibitors2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine2
Levodopa Augmentation of Antipsychotics for Persistent Negative Symptoms in Schizophrenia2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress2
Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder2
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use2
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders2
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder2
The Efficacy of Methylphenidate Use in Children Diagnosed With Attention Deficit Hyperactivity Disorder With Emotional Impulsivity Symptoms2
A Call for the Study of Zuranolone as a Novel Treatment for Premenstrual Dysphoric Disorder2
Citalopram Associated with the Development of Tinnitus in an Adolescent Girl2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India2
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania2
Hypertensive Emergency and Stroke With Medication Interaction2
Hypotension and Peripheral Edema With Moclobemide2
Endoxifen Approval for Bipolar Disorder in India2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine2
Monoamine Oxidase Inhibitors for Trichotillomania2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals2
A Systematic Review to Determine if Family History of Response to Medication Predicts Outcome in Mood Disorders2
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Re2
The Impact of Antidepressant Medications on Sleep in Children2
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression2
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia2
Pleural Effusion Associated With Divalproex Sodium2
Blepharospasm Arising From Escitalopram Use2
0.2488100528717